Cargando…

Galectins as Cancer Biomarkers

Galectins are a group of proteins that bind β-galactosides through evolutionarily conserved sequence elements of the carbohydrate recognition domain (CRD). Proteins similar to galectins can be found in very primitive animals such as sponges. Each galectin has an individual carbohydrate binding prefe...

Descripción completa

Detalles Bibliográficos
Autores principales: Balan, Vitaly, Nangia-Makker, Pratima, Raz, Avraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645499/
https://www.ncbi.nlm.nih.gov/pubmed/23658855
http://dx.doi.org/10.3390/cancers2020592
_version_ 1782268509321953280
author Balan, Vitaly
Nangia-Makker, Pratima
Raz, Avraham
author_facet Balan, Vitaly
Nangia-Makker, Pratima
Raz, Avraham
author_sort Balan, Vitaly
collection PubMed
description Galectins are a group of proteins that bind β-galactosides through evolutionarily conserved sequence elements of the carbohydrate recognition domain (CRD). Proteins similar to galectins can be found in very primitive animals such as sponges. Each galectin has an individual carbohydrate binding preference and can be found in cytoplasm as well as in the nucleus. They also can be secreted through non-classical pathways and function extra-cellularly. Experimental and clinical data demonstrate a correlation between galectin expression and tumor progression and metastasis, and therefore, galectins have the potential to serve as reliable tumor markers. In this review, we describe the expression and role of galectins in different cancers and their clinical applications for diagnostic use.
format Online
Article
Text
id pubmed-3645499
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-36454992013-05-06 Galectins as Cancer Biomarkers Balan, Vitaly Nangia-Makker, Pratima Raz, Avraham Cancers (Basel) Review Galectins are a group of proteins that bind β-galactosides through evolutionarily conserved sequence elements of the carbohydrate recognition domain (CRD). Proteins similar to galectins can be found in very primitive animals such as sponges. Each galectin has an individual carbohydrate binding preference and can be found in cytoplasm as well as in the nucleus. They also can be secreted through non-classical pathways and function extra-cellularly. Experimental and clinical data demonstrate a correlation between galectin expression and tumor progression and metastasis, and therefore, galectins have the potential to serve as reliable tumor markers. In this review, we describe the expression and role of galectins in different cancers and their clinical applications for diagnostic use. MDPI 2010-04-20 /pmc/articles/PMC3645499/ /pubmed/23658855 http://dx.doi.org/10.3390/cancers2020592 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Balan, Vitaly
Nangia-Makker, Pratima
Raz, Avraham
Galectins as Cancer Biomarkers
title Galectins as Cancer Biomarkers
title_full Galectins as Cancer Biomarkers
title_fullStr Galectins as Cancer Biomarkers
title_full_unstemmed Galectins as Cancer Biomarkers
title_short Galectins as Cancer Biomarkers
title_sort galectins as cancer biomarkers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645499/
https://www.ncbi.nlm.nih.gov/pubmed/23658855
http://dx.doi.org/10.3390/cancers2020592
work_keys_str_mv AT balanvitaly galectinsascancerbiomarkers
AT nangiamakkerpratima galectinsascancerbiomarkers
AT razavraham galectinsascancerbiomarkers